Lockdown and clinically extremely vulnerable

The government have issued new guidance in respect of the new lockdown for those who are considered clinically extremely vulnerable. As this relates to many of our clients we thought we ought to let you know what they say.


Restrictions come in today for the whole of England but further specific guidance has been issued if you have one of the following:-


•solid organ transplant recipients

•those with specific cancers:

•people with cancer who are undergoing active chemotherapy

•people with lung cancer who are undergoing radical radiotherapy

•people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment

•people having immunotherapy or other continuing antibody treatments for cancer

•people having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors or PARP inhibitors

•people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs


•those with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)

•those with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease)

•those on immunosuppression therapies sufficient to significantly increase risk of infection

•adults with Down’s syndrome

•adults on dialysis or with chronic kidney disease (stage 5)

•women who are pregnant with significant heart disease, congenital or acquired

•other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs. GPs and hospital clinicians have been provided with guidance to support these decisions


You should also have received a letter from NHS England or your GP advising that you are clinically extremely vulnerable previously.